BioSpace News Archive

Alentis Therapeutics, the biotechnology company developing breakthrough treatments for organ fibrosis and fibrotic-associated cancers, announced the appointment of Andrea Pellacani, MD, PhD as Chief Medical Officer.

Genesis Therapeutics announced that it has entered into a strategic collaboration with Eli Lilly and Company to discover novel therapies for up to five targets across a range of therapeutic areas.

CB Scientific. Inc., a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products and services, announces that effectively immediately James Ott has joined the Company’s executive management team as its Chief Technology Officer.

Zimmer Biomet Holdings, Inc. reported financial results for the quarter ended March 31, 2022.

Karuna Therapeutics, Inc. announced that Andrew Miller, Ph.D., founder and chief operating officer, will participate in a fireside chat at the 2022 RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, 2022, at 8:00 a.m. ET.

Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, reported business highlights and financial results for the first quarter ended March 31, 2022.

Ad-Tech Medical today announced that Drew Rannells has joined Ad-Tech’s sales team.

Pfizer Inc. reported strong financial results for first-quarter 2022 and updated certain components of 2022 financial guidance.

NMD Pharma A/S announces that it has expanded its presence in the US with the creation of a new US subsidiary, NMD Pharma US, Inc.

Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that new nonclinical data will be presented at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting.